Breaking down new drugs, peptides, and emerging therapies. Evidence-first.
* By joining the newsletter or signing in, you agree to the Terms of Service and Privacy Policy.
* By joining the newsletter or signing in, you agree to the Terms of Service and Privacy Policy.
24:43Semaglutide Explained: Mechanism, Evidence, & Unintended Benefits
30:53Pinealon Explained: how it works, and what the evidence shows
32:41SLU-PP-332 & 915 Explained: Evidence, Risks, and The Human Trial Gap
35:53CJC/Ipamorelin Explained: Mechanism, Evidence, Risks, and DAC
56:13Leaky Gut Explained: Mechanism, Evidence, LPS, and Endotoxins
1:35:34Retatrutide Explained: Mechanism, Evidence, and What the Human Trials Show
11:11Semax Explained: A Biochemical Perspective on The Cognition Peptide
23:27Tesamorelin Explained: The FDA-Approved Peptide for Reducing Visceral Belly Fat
21:53Epitalon Explained: Mechanism, Evidence, Risks, and How It Could Promote Longevity
33:53KPV Explained: The Anti-Inflammatory Peptide
29:16Could BPC-157 Fuel Cancer?
51:56Melanotan I and II Explained: Tanning and The Melanocortin System
18:29Tirzepatide Explained: GLP-1 vs GIP receptors
30:25MOTS-c and SS-31 Explained: How They Work and What the Evidence Shows
43:48VERVE-102: A Groundbreaking Gene Editing Therapy for Hypercholesterolemia
15:13TB-500 Explained: Mechanism, Evidence, Risks, and How It Compares to BPC-157
28:14BPC-157 Explained: Mechanism, Evidence, Risks, and the Human Trial Gap
15:05Trevogrumab Explained: The Muscle-Sparing GLP-1 Add-On
31:01Is Retatrutide's Heart Rate Spike Dangerous?
46:57GHK-Cu Explained: The Science Behind The Copper Peptide
31:10Retatrutide Explained: The Triple-Agonist After Ozempic and Mounjaro